Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001601485-21-000011)

Filing Details

Accession Number:: 0001601485-21-000011
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-04-15 16:05:51
Reporting Period:: 2021-04-15

Accepted Time:: 2021-04-15 16:05:51
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1601485	Angion Biomedica Corp.	ANGN	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1568249	J Jennifer Rhodes	C/O Angion Biomedica Corp. 51 Charles Lindbergh Blvd. Uniondale NY 11553	See Remarks	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2021-04-15	399	$15.01	33,887	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

The shares reported in this Form 4 were effected pursuant to a 10b-5-1 trading plan adopted by the reporting person solely to satisfy tax or other government withholding obligations in connection with the vesting of shares subject to a Restricted Stock Units ("RSUs") of the Issuer.